US Stock MarketDetailed Quotes
PHGE BiomX
- 0.7285
- +0.0001+0.01%
Close Nov 4 16:00 ET
- 0.7015
- -0.0270-3.71%
Post 17:47 ET
13.04MMarket Cap-186P/E (TTM)
0.8250High0.6200Low121.09KVolume0.7001Open0.7284Pre Close85.29KTurnover0.88%Turnover RatioLossP/E (Static)17.90MShares8.550052wk High-2.61P/B10.07MFloat Cap0.620052wk Low--Dividend TTM13.82MShs Float119.0000Historical High--Div YieldTTM28.14%Amplitude0.6200Historical Low0.7040Avg Price1Lot Size
About BiomX Company
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolPHGE
Company NameBiomX
Listing DateDec 14, 2018
Founded2015
CEOMr. Jonathan Solomon
MarketAMEX
Employees71
Fiscal Year Ends12-31
Address708 Quince Orchard Road,Suite 205
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Websitehttp://www.biomx.com
Company Executives
- Name
- Position
- Salary
- Jonathan Solomon
- Director and Chief Executive Officer
- 1.12M
- Marina Wolfson
- Senior Vice President, Finance and Operations, Principal Accounting Officer and Chief Financial Officer
- 428.26K
- Assaf Oron
- Chief Business Officer
- --
- Dr. Merav Bassan, PhD
- Chief Development Officer
- 590.93K
- Dr. Russell Greig
- Chairman of the Board
- 161.58K
- Jonathan S. Leff
- Director
- --
- Gregory Merril
- Director
- --
- Dr. Jesse Goodman, M.D.,M.P.H.
- Director
- --
- Edward Williams
- Independent Director
- 8.79K
- Dr. Alan C. Moses, F.A.C.P.,M.D.
- Independent Director
- 81.43K
- Susan Blum
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data